Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: A randomized, double-blind, controlled study

Diabetes, Metabolic Syndrome and Obesity

Volumn 6, Issue , 2013, Pages 275-284

  Usharani, Pingali ^a   Fatima, Nishat ^a   Muralidhar, Nizampatnam ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Atorvastatin; Endothelial dysfunction; Phyllanthus emblica; Type 2 diabetes

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; EMBLICA OFFICINALIS EXTRACT; EMBLICANIN A; EMBLICANIN B; GLUTATHIONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; PEDUNCULAGIN; PLACEBO; PUNIGLUCONIN; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ENDOTHELIAL DYSFUNCTION; EVENING DOSAGE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS;

EID: 84880777043     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S46341     Document Type: Article

References (37)

1. Sowers James R, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease. An update. Hypertension. 2001;37: 1053-1059.
2. Winner N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol. 2004;44:397-405.
3. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyorala K. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor: the DECODE Study. Diabetologia. 2004;47:2118-2128.
4. Stehouwer CD, Lambert J, Donker AJ, Hinsbergh V W. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res. 1997;34:55-68.
5. Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006;60:308-314.
6. Stehouwer CD, Gall MA, Twisk J W, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes. 2002;51:1157-1165.
7. Lapice E, Maione S, Patti L, et al. Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy non-obese people. Diabetes Care. 2009;32:1734-1736.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
9. Weisberg S P, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
10. Rahat K, Chatwal S, Arora S, et al. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase-lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes. 2013;6:50-56.
11. Antony B, Merina B, Sheeba V, Mukkadan J. Effect of standardized Amla extract on atherosclerosis and dyslipidemia. Indian J Pharm Sci. 2006;68:437-441.
12. Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of amla fruit (Emblica offcinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62:606-616.
13. Antony B, Benny M, Kaimal TN. A pilot clinical study to evaluate the effect of Emblica offcinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia. Indian J Clin Biochem. 2008;23: 378-381.
14. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simavastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simavastatin Survival Study(4S). Diabetes Care. 1997;20:614-620.
15. Tantikosoom W, Thinkhamrop B, Songsak K, Jarernsiripornkul N, Srinakarin J, Ojongpianl S. Randomized trial of Atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level. J Med Assoc Thai. 2005;88:399-406.
16. Tousoulis D, Antoniades C, Vassiliadou C, et al. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure. Eur J Heart Failure. 2005;7:1126-1132.
17. Chowienezyk PJ, Kelly R P, MacCallum H, et al. Photoplethysmographic assessment of pulse wave refection: blunted response to endothelium dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol. 1999;34:2007-2014.
18. Naidu MUR, Sridhar Y, UshaRani P, Mateen AA. Comparison of two β2 adrenoceptor agonists by different routes of administration to assess human endothelial function. Indian J Pharmacol. 2007;39:168-169.
19. Millaesseau SC, Kelly R P, Ritter JM, Chowienczyk PJ. Determination of age related increases in large artery stiffness by digital pulse contour analysis. Clin Sci. 2002;103:371-377.
20. Vidyasagar J, Karunaka N, Reddy MS, Rajnarayan K, Surender T, Krishna DR. Oxidative stress and antioxidant status in acute organophos-phorous insecticide poisoning. Indian J Pharmacol. 2004;36:76-79.
21. Katrina MM, Michael GE, David AW. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Biol Chem. 2001;5:62-71.
22. Elman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82: 70-77.
23. Schalkwijk CG, Stehouwer CDA. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci. 2005;109: 143-159.
24. Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mel-litus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 2008;9:243-250.
25. Assunta P, Elena A. Chronic hyperglycemia and nitric oxide bioavaili-ability play a pivotal role in pro-atherogenic vascular modifications. Genes Nutr. 2007;17:195-208.
26. Duncan B, Meeking D, Kenneth S, Cummings M. Endothelial dysfunction and pre-symptomatic atherosclerosis in type 1 diabetes - pathogenesis and identification. Br J Diabetes Vasc Dis. 2003;3:27-34.
27. Shahid SM, Mahboob T. Diabetes and hypertension: correlation between glycosylated hemoglobin (HbA1c) and serum nitric oxide (NO). Aust J Basic Appl Sci. 2009;3:1323-1327.
28. Tsai DC, Chiou SH, Lee FL, Peng CH, Kuo YH, Chen C F. Possible involvement of nitric oxide in the progression of diabetic retinopathy. Ophthalmologica. 2003;217:342-346.
29. Patel SS, Goyal RK. Emblica offcinalis Geart. A comprehensive review on phytochemistry, pharmacology and ethnomedicinal uses. Research Journal of Medicinal Plants. 2012;6(1):6-16.
30. Ceriello A, Assaloni R, Da Ros R, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and infammation in type 2 diabetic patients. Circulation. 2005;111:2518-2524.
31. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart. Phytomedicine. 2002;9: 171-174.
32. Mathur R, Sharma A, Dixit V P, Varma M. Hypolipidemic effect of fruit juice of Emblica offcinalis in cholesterol-fed rabbits. J Ethnopharmacol. 1996;50:61-68.
33. Suanarunsawat T, Devakul Na Ayutthaya W, Songsak T, Thirawarapan S, Poungshompoo S. Antioxidant activity and lipid-lowering effect of essential oils extracted from Ocimum sanctum leaves in rats fed with a high cholesterol diet. J Clin Biochem Nutr. 2010;1:52-59.
34. Bhattacharya A, Chatterjee A, Ghoshal S, Bhattacharya SK. Antioxidant activity of active tannoid principle of Emblica offcinalis (Amla). Indian J Exp Biol. 2000;37:676-680.
35. Anila L, Vijyalaxmi NR. Flavanoids from Emblica offcinalis and Magnifera indica. Effectiveness for dyslipidemia. J Ethnopharmacol. 2002;79:81-87.
36. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of infammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237-242.
37. Tajiri Y, Mimura K, Umeda F. High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes mellitus. Obes Res. 2005;13: 1810-1816.